论文部分内容阅读
目的:阐述民族药白英研究及专利的现状。方法:以“白英”“白毛藤”“Solanum lyratum Thunb.”“Solanum lyratum”为主题词,检索1960-2016年期间收载于“中国知网”“Pubmed”的文献。结果:白英相关论文218篇,专利375项;论文内容以单味药抗肿瘤机制研究为主,复方临床经验及实验研究次之;375项专利中,复方专利涉及治疗肿瘤多达206项,其他类计162项,单味药专利仅7篇。结论:白英论文与专利文献中,涉及抗肿瘤研究的量最大,提示应加强白英抗肿瘤机制与药效研究,为研发有效的抗肿瘤新药及临床治疗肿瘤提供实验参考。
Objective: To elaborate the current situation of the research and patent of ethnic medicine Baiying. METHODS: Using the keywords “Solanum lyratum Thunb. ” And “Solanum lyratum” as the keywords of “White British”, “White Solanum” “Solanum lyratum” “Pubmed ” literature. Results: There were 218 articles of Baiying and 375 patents. The content of the thesis was mainly on the study of anti-tumor mechanism of single herbs, followed by clinical experience and experimental study. Among 375 patents, the compound patent involved in the treatment of up to 206 tumors, 162 items in other categories, and only 7 patents of single medicine. Conclusion: In the white papers and patent literatures, the amount of anti-tumor research is the largest, suggesting that anti-tumor mechanism and efficacy should be strengthened, providing experimental reference for the development of effective anti-tumor drugs and clinical treatment of tumors.